Participants 53 93 7
in postmenopausal breast cancer patients
Participants 429 510 5
In metastatic breast cancer patients with previous exposure to endocrine therapy,
Participants 1041 1183 4
We recollected primary tumor tissue from patients who participated in a randomized trial of adjuvant tamoxifen (1-3 years) versus observation.
